Moderna pivots to infectious disease & oncology, targeting cash break-even by 2028. Click here to see why I rate MRNA stock a ...

Moderna (MRNA) has been quietly grinding higher, with the stock up roughly 11% over the past month and 12% in the past 3 ...

Stocks that are trending today. Stéphane Bancel, CEO of Moderna , said: "We remain focused on our strategy to build a large ...

On Tuesday, Moderna MRNA got a positive adjustment to its Relative Strength (RS) Rating, from 67 to 73. This exclusive rating ...

Elie Honig, a former federal and state prosecutor and CNN senior legal analyst, has closely followed the turmoil in Chicago ...

In the latest trading session, Moderna (MRNA) closed at $33.86, marking a -5.66% move from the previous day. The stock trailed the S&P 500, which registered a daily gain of 0.01%. Meanwhile, the Dow ...

Investors flocked to Moderna (NASDAQ: MRNA) stock in the early days of the pandemic for one big reason: The company sold one of the world's most-needed products, a coronavirus vac ...

In the latest trading session, Moderna (MRNA) closed at $30.41, marking a -2.38% move from the previous day. This move lagged the S&P 500's daily loss of 0.14%. On the other hand, the Dow registered ...

Asian shares are trading mixed after Wall Street pulled back from its recent records and as political uncertainty brewed in ...

Wall Street pulled back from its records on Tuesday following a mixed start to the latest profit reporting season for big U.S ...

Wall Street pulled back from its records on Tuesday following a mixed start to the latest profit reporting season for big U.S ...